GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback